PPM1α overexpression in the liver showed great improvement in insulin sensitivity under statin treatment and further lipid metabolism (Figure 7), suggesting that liver‐specific PPM1α overexpression could be used as a treatment for insulin resistance or even other metabolic syndromes. This evidence concerns the gene INS and metabolic syndrome.